Skip to main content

Want a detailed portfolio tracker?

Silexion Therapeutics (SLXN) P/E (2024 - 2026)

Silexion Therapeutics (SLXN) P/E from Aug 16, 2024 to Jul 21, 2026. The TTM Silexion Therapeutics (SLXN) P/E is 7.27. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Silexion Therapeutics (SLXN)

YearP/EChange
20267.27-86.93%
202555.60-93.63%
2024873.06N/A

Comparison Silexion Therapeutics (SLXN) P/E with competitors

Silexion Therapeutics (SLXN) P/E is 7.27.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-99.98%
NBYStablecoin Development Corp0.00-99.94%
ENLVEnlivex Ltd0.07-98.97%
FGENFibroGen Inc0.24-96.70%
CHRSCoherus Biosciences Inc0.85-88.33%
FBIOFortress Biotech Inc0.95-86.94%
ORMPOramed Pharmaceuticals Inc1.50-79.32%
AGENAgenus Inc3.01-58.59%
INVAInnoviva Inc3.15-56.61%
VXRTVaxart Inc3.55-51.16%
CRMDCorMedix Inc3.63-50.08%
CVACCureVac N.V.4.45-38.84%
GLPGGalapagos NV4.86-33.15%
SRPTSarepta Therapeutics Inc4.88-32.83%
ABEOAbeona Therapeutics Inc5.39-25.88%
ABUSArbutus Biopharma Corp5.60-23.02%
ZVRAZevra Therapeutics Inc5.89-19.00%
SPROSpero Therapeutics Inc6.23-14.31%
CGENCompugen Ltd6.31-13.13%
RIGLRigel Pharmaceuticals6.87-5.45%
OMEROmeros Corporation9.26+27.38%
AUPHAurinia Pharmaceuticals Inc9.58+31.87%
PLXProtalix BioTherapeutics Inc10.89+49.84%
ACADAcadia Pharmaceuticals Inc11.73+61.36%
TBPHTheravance Biopharma Inc12.26+68.70%
ADMAAdma Biologics Inc12.42+70.85%
HRMYHarmony Biosciences Holdings Inc13.82+90.14%
SABSSAB Biotherapeutics Inc14.14+94.49%
NAGENiagen Bioscience Inc14.82+103.87%
INCYIncyte Corp15.82+117.69%
REGNRegeneron Pharmaceuticals Inc15.86+118.16%
PBYIPuma Biotechnology Inc17.32+138.23%
CPRXCatalyst Pharmaceuticals Inc17.44+139.93%
EXELExelixis Inc17.54+141.29%
TGTXTG Therapeutics Inc18.97+160.94%
MDXGMimedx Group Inc20.55+182.76%
XOMAXOMA Royalty Corp22.87+214.72%
ARGXArgen X SE24.30+234.30%
CTMXCytomX Therapeutics Inc24.82+241.50%
XOMAOXOMA Royalty Corp25.34+248.70%
HALOHalozyme Therapeutics Inc25.62+252.54%
XOMAPXOMA Royalty Corp25.67+253.18%
VRTXVertex Pharmaceuticals Inc27.99+285.16%
RPRXRoyalty Pharma plc - Class A28.69+294.69%
SLNOSoleno Therapeutics Inc29.02+299.20%
ASNDAscendis Pharma A/S30.09+313.93%
LGNDLigand Pharmaceuticals Inc - Class B37.91+421.61%
APLSApellis Pharmaceuticals Inc39.02+436.87%
BMRNBiomarin Pharmaceutical Inc42.21+480.77%
KRYSKrystal Biotech Inc45.34+523.85%
ONCBeiGene Ltd69.54+856.76%
PHARPharming Group N.V.75.03+932.23%
TECHBio-Techne Corp101.96+1302.78%
VCELVericel Corp109.92+1412.34%
ALNYAlnylam Pharmaceuticals Inc117.96+1523.01%
GMABGenmab140.29+1830.18%
TLXTelix Pharmaceuticals Ltd162.15+2130.96%
CORTCorcept Therapeutics Inc212.86+2828.58%